latest news releases from the newsroom
Generex Biotechnology Corp.
Generex to Pursue Regulatory Path for Application of Generex Oral-lyn(tm) for Veterinary Market
WORCESTER, Mass., March 26, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that as a result of increased demand, the company plans to pursue the regulatory path for the submission of Generex Oral-lyn(tm) with the veterinary arms of global health agencies for therapeutic use in cats and dogs with diabetes.
Holzer Holzer & Fistel, LLC
Holzer Holzer & Fistel, LLC Announces Investigation Into the Purchase of Hearst-Argyle Television, Inc. by Hearst Corp.
ATLANTA, March 26, 2009 (GLOBE NEWSWIRE) -- Holzer Holzer & Fistel, LLC is investigating possible violations of state law for, among other things, breaches of fiduciary duty in connection with a proposed buyout of Hearst-Argyle Television, Inc. (NYSE:HTV) by Hearst Corp. Hearst Corp. has offered to purchase a majority of the outstanding shares of Hearst-Argyle Television, Inc. for $4.00 per share. Hearst Corp. currently owns approximately 67 percent of Hearst-Argyle's outstanding Class A shares and 100 percent of its outstanding Class B shares. If consummated, Hearst-Argyle Television, Inc. will become a wholly-owned subsidiary of Hearst Corp.